Corcept Therapeutics Inc (CORT) 6.44 $CORT
3 Soaring Biotech Stocks Under $10 -- Are They Buys?
Todd Campbell, The Motley Fool - Motley Fool - Wed Apr 22, 9:03AM CDT
There is probably no industry as prone to jaw-dropping pops and drops as biotechnology, so it might not be surprising that these three low-price biotech stocks are racking up remarkable returns so far this year. Although each of these companies has...
CORT: 6.44 (+0.38), NVS: 103.45 (-0.62), EXEL: 3.12 (+0.05), ARRY: 7.25 (-0.10)
Corcept Therapeutics (CORT) Looks Good: Stock Up 83.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 09, 7:51AM CDT
Corcept Therapeutics Incorporated (CORT) was a big mover last session, as its shares rose roughly 29% on the day.
FLML: 15.84 (-0.33), CORT: 6.44 (+0.38)
Corcept's Warrants Exercised, Invest in Korlym, Pipeline - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 02, 1:41PM CDT
Corcept Therapeutics Incorporated (CORT) announced that its investors have exercised their warrants issued to purchase the company's common stock.
MNK: 122.95 (-2.22), LCI: 66.45 (-0.28), SLXP: 172.96 (+0.15), CORT: 6.44 (+0.38)
Warrant Exercises Generate $17.2 Million; Proceeds to Advance Next-Generation Compounds and Support Commercialization of Korlym(R)
Marketwired - Wed Apr 01, 3:05PM CDT
Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, announced today the exercise of warrants to purchase the company's common stock. The company issued the warrants to accredited investors in two private placements, one that was completed in March 2008 and the other in March 2012. Together, the warrant exercises generated gross proceeds to the company of $17.2 million.
CORT: 6.44 (+0.38)
Cortendo AB names A. Brian Davis as CFO and Stephen Long as chief legal officer
M2 - Tue Mar 24, 6:43AM CDT
Biopharmaceutical company Cortendo AB (NOTC-A:CORT) announced on Monday that it has appointed A. Brian Davis as chief financial officer (CFO) and Stephen Long to the position of chief legal officer.
CORT: 6.44 (+0.38)
The Best Small Cap Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Sat Mar 21, 11:24PM CDT
DMND: 30.74 (+0.01), PMC: 28.80 (+0.80), MATW: 50.74 (+0.08), ELLI: 57.00 (-0.45), WWE: 14.19 (+0.04), SILC: 41.72 (+0.45), SGMO: 14.37 (-0.03), TRNX: 25.96 (-0.06), OFIX: 36.22 (-0.21), AFFX: 12.57 (-0.13), CHE: 122.49 (+0.25), BABY: 41.64 (+1.71), HBIO: 6.06 (-0.29), IART: 59.75 (-0.26), SONC: 30.75 (+0.14), SNCR: 51.87 (+0.02), CNMD: 49.35 (+0.36), BJRI: 50.54 (-1.00), NLNK: 53.12 (-0.07), ANAC: 66.45 (-0.22), XSD: 89.10 (+0.13), PRSC: 49.43 (+0.42), RRGB: 80.99 (-2.02), IPAR: 32.16 (+0.16), ALOG: 87.92 (+0.38), DIOD: 28.02 (+0.12), NSIT: 29.01 (+0.22), LGND: 87.71 (-0.58), DEPO: 27.14 (+0.65), ASTE: 42.80 (+0.16), DYAX: 28.12 (+0.15), ECOL: 48.69 (+0.16), PFPT: 58.45 (-0.45), MTSI: 34.46 (-0.27), IRWD: 15.07 (-0.19), ABAX: 63.25 (-0.09), FLDM: 43.04 (-1.36), SCSS: 34.12 (+0.30), ANIP: 69.79 (+1.24), FORM: 9.44 (+0.05), BEAT: 8.82 (-0.13), QLGC: 15.08 (+0.44), ADUS: 27.60 (-0.33), PENX: 18.98 (+0.14), EBIX: 29.77 (+0.86), CORT: 6.44 (+0.38), SWHC: 14.68 (-0.12), OCFC: 16.93 (+0.01)
Nasdaq stocks posting largest percentage increases
AP - Fri Mar 20, 12:25PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
BIIB: 423.57 (+1.46), GLMD: 10.00 (-0.12), HIIQ: 7.36 (-0.24), VTAE: 14.04 (+0.02), CLDN: 13.59 (-2.77), ATRA: 63.79 (+7.64), VBLT: 4.37 (-0.08), CORT: 6.44 (+0.38), FPRX: 24.07 (-0.85)
Corcept Therapeutics (CORT) Is Weak On High Volume Today
at The Street - Fri Mar 20, 9:02AM CDT
Trade-Ideas LLC identified Corcept Therapeutics (CORT) as a weak on high relative volume candidate
CORT: 6.44 (+0.38)
111.8% Return Seen to Date on SmarTrend Corcept Therapeutics Call (CORT)
Comtex SmarTrend(R) - Wed Mar 18, 4:51PM CDT
SmarTrend identified an Uptrend for Corcept Therapeutics (NASDAQ:CORT) on June 12th, 2014 at $2.47. In approximately 9 months, Corcept Therapeutics has returned 111.76% as of today's recent price of $5.22.
CORT: 6.44 (+0.38)
Cortendo announces new board members at Extraordinary General Meeting
M2 - Wed Mar 18, 3:20AM CDT
Cortendo AB (NOTC-A:CORT), a biopharmaceutical company focused on orphan endocrine disorders, announced on Tuesday that at the Extraordinary General Meeting held in Goteborg, John H. Johnson was elected, for the period until the end of the next annual general meeting, as new chairman of the board of directors.
CORT: 6.44 (+0.38)
Corcept Therapeutics (CORT) Jumps: Stock Rises 14.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 12, 8:04AM CDT
Corcept Therapeutics Incorporated (CORT) was a big mover last session, as the company saw its shares rise over 14% on the day.
LCI: 66.45 (-0.28), CORT: 6.44 (+0.38)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Mar 11, 11:47AM CDT
BAK: 8.04 (+0.21), MELA: 1.52 (-0.14), ZGNX: 1.63 (-0.02), EOX: 0.61 (-0.02), MRD: 19.19 (+0.06), ULTR: 1.36 (+0.01), BLT: 13.63 (+0.28), RESN: 3.77 (-0.06), GBSN: 4.98 (+1.44), CYTX: 0.96 (-0.09), WRES: 1.15 (-0.02), MTL: 1.29 (-0.01), VRA: 14.16 (-0.69), CTP: 3.89 (+0.08), ENRJ: 1.75 (+0.05), CORT: 6.44 (+0.38), CBMG: 32.14 (+2.21), SPP: 2.14 (+0.07), CAPN: 6.99 (-0.29), SZYM: 3.71 (-0.06)
Piper upgrades Corcept and sets a $9 price target
Seeking Alpha - at Seeking Alpha - Wed Mar 11, 10:54AM CDT
CORT: 6.44 (+0.38)
Upgrade Alert for Corcept Therapeutics (CORT)
Comtex SmarTrend(R) - Wed Mar 11, 7:07AM CDT
Corcept Therapeutics (NASDAQ:CORT) was upgraded from Neutral to Overweight at Piper Jaffray today. The stock closed yesterday at $3.37 on volume of 144,000 shares, above average daily volume of 117,000. Corcept Therapeutics (NASDAQ:CORT) is currently priced 18.4% above its average consensus analyst price target of $2.75. Corcept Therapeutics shares have support at the 50-day moving average (MA) of $3.13 and additional support at the 200-day MA of $2.86.
CORT: 6.44 (+0.38)
How Alan Leong Of BioWatch News Keeps Successful Biotech Investing Simple
Life Sciences Report - Seeking Alpha - Thu Mar 05, 4:53PM CST
Biotechnology can be daunting to comprehend, but understanding is critical to successful investment. BioWatch News Founder Alan Leong has a nose for growth names, and his goal is to make their technology platforms clear to investors who might not...
CTRV: 3.13 (-0.07), GLMD: 10.00 (-0.12), PTBI: 3.37 (+0.20), CNAT: 6.31 (-0.15), GALT: 3.29 (+0.01), SRNE: 10.36 (-0.43), CELG: 115.54 (+0.72), GILD: 104.18 (-1.02), KITE: 57.56 (-1.43), CFRX: 5.39 (-0.05), ICPT: 280.45 (-8.26), JUNO: 55.72 (-0.68), CORT: 6.44 (+0.38)
Corcept reports 4Q loss
Automated Insights - Wed Mar 04, 3:54PM CST
MENLO PARK, Calif. (AP) _ Corcept Therapeutics Inc. (CORT) on Wednesday reported a loss of $3.9 million in its fourth quarter.
CORT: 6.44 (+0.38)
Corcept Therapeutics beats by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 3:15PM CST
CORT: 6.44 (+0.38)
The Top Small Cap Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Sun Feb 22, 2:51AM CST
MATW: 50.74 (+0.08), RTIX: 5.69 (-0.10), ELLI: 57.00 (-0.45), KFRC: 22.02 (-0.13), SILC: 41.72 (+0.45), SGMO: 14.37 (-0.03), AFFX: 12.57 (-0.13), BABY: 41.64 (+1.71), HBIO: 6.06 (-0.29), EXAM: 42.52 (-0.16), IART: 59.75 (-0.26), UEIC: 57.71 (+0.45), CNMD: 49.35 (+0.36), BJRI: 50.54 (-1.00), NLNK: 53.12 (-0.07), CTRN: 24.27 (+0.16), ANAC: 66.45 (-0.22), CSU: 26.62 (+0.09), RRGB: 80.99 (-2.02), DIOD: 28.02 (+0.12), DEPO: 27.14 (+0.65), DYAX: 28.12 (+0.15), FARO: 44.64 (-0.93), PERY: 24.97 (-0.22), PACB: 5.90 (-0.07), PFPT: 58.45 (-0.45), MTSI: 34.46 (-0.27), IRWD: 15.07 (-0.19), ABAX: 63.25 (-0.09), SCSS: 34.12 (+0.30), ANIP: 69.79 (+1.24), FORM: 9.44 (+0.05), BEAT: 8.82 (-0.13), QLGC: 15.08 (+0.44), PENX: 18.98 (+0.14), EBIX: 29.77 (+0.86), CORT: 6.44 (+0.38), UTMD: 56.00 (+0.90), DAVE: 29.37 (+0.05), SWHC: 14.68 (-0.12)
Cortendo's resolutions on new share issues at Extraordinary General Meeting approved
M2 - Wed Feb 04, 5:28AM CST
Cortendo AB (NOTC-A:CORT)(OTC:CRTOF), a biopharmaceutical company focused on orphan endocrine disorders, on Tuesday reported the holding of an Extraordinary General Meeting in Goteborg.
CORT: 6.44 (+0.38)
Earnings Update: Corcept Therapeutics
Clinically Sound Investor - at Seeking Alpha - Fri Jan 30, 1:13PM CST
CORT: 6.44 (+0.38)
3 Soaring Biotech Stocks Under $10 -- Are They Buys?
Todd Campbell, The Motley Fool - Motley Fool - Wed Apr 22, 9:03AM CDT
There is probably no industry as prone to jaw-dropping pops and drops as biotechnology, so it might not be surprising that these three low-price biotech stocks are racking up remarkable returns so far this year. Although each of these companies has...
CORT: 6.44 (+0.38), NVS: 103.45 (-0.62), EXEL: 3.12 (+0.05), ARRY: 7.25 (-0.10)
Corcept Therapeutics (CORT) Looks Good: Stock Up 83.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 09, 7:51AM CDT
Corcept Therapeutics Incorporated (CORT) was a big mover last session, as its shares rose roughly 29% on the day.
FLML: 15.84 (-0.33), CORT: 6.44 (+0.38)
Corcept's Warrants Exercised, Invest in Korlym, Pipeline - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 02, 1:41PM CDT
Corcept Therapeutics Incorporated (CORT) announced that its investors have exercised their warrants issued to purchase the company's common stock.
MNK: 122.95 (-2.22), LCI: 66.45 (-0.28), SLXP: 172.96 (+0.15), CORT: 6.44 (+0.38)
Warrant Exercises Generate $17.2 Million; Proceeds to Advance Next-Generation Compounds and Support Commercialization of Korlym(R)
Marketwired - Wed Apr 01, 3:05PM CDT
Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, announced today the exercise of warrants to purchase the company's common stock. The company issued the warrants to accredited investors in two private placements, one that was completed in March 2008 and the other in March 2012. Together, the warrant exercises generated gross proceeds to the company of $17.2 million.
CORT: 6.44 (+0.38)
Cortendo AB names A. Brian Davis as CFO and Stephen Long as chief legal officer
M2 - Tue Mar 24, 6:43AM CDT
Biopharmaceutical company Cortendo AB (NOTC-A:CORT) announced on Monday that it has appointed A. Brian Davis as chief financial officer (CFO) and Stephen Long to the position of chief legal officer.
CORT: 6.44 (+0.38)
The Best Small Cap Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Sat Mar 21, 11:24PM CDT
DMND: 30.74 (+0.01), PMC: 28.80 (+0.80), MATW: 50.74 (+0.08), ELLI: 57.00 (-0.45), WWE: 14.19 (+0.04), SILC: 41.72 (+0.45), SGMO: 14.37 (-0.03), TRNX: 25.96 (-0.06), OFIX: 36.22 (-0.21), AFFX: 12.57 (-0.13), CHE: 122.49 (+0.25), BABY: 41.64 (+1.71), HBIO: 6.06 (-0.29), IART: 59.75 (-0.26), SONC: 30.75 (+0.14), SNCR: 51.87 (+0.02), CNMD: 49.35 (+0.36), BJRI: 50.54 (-1.00), NLNK: 53.12 (-0.07), ANAC: 66.45 (-0.22), XSD: 89.10 (+0.13), PRSC: 49.43 (+0.42), RRGB: 80.99 (-2.02), IPAR: 32.16 (+0.16), ALOG: 87.92 (+0.38), DIOD: 28.02 (+0.12), NSIT: 29.01 (+0.22), LGND: 87.71 (-0.58), DEPO: 27.14 (+0.65), ASTE: 42.80 (+0.16), DYAX: 28.12 (+0.15), ECOL: 48.69 (+0.16), PFPT: 58.45 (-0.45), MTSI: 34.46 (-0.27), IRWD: 15.07 (-0.19), ABAX: 63.25 (-0.09), FLDM: 43.04 (-1.36), SCSS: 34.12 (+0.30), ANIP: 69.79 (+1.24), FORM: 9.44 (+0.05), BEAT: 8.82 (-0.13), QLGC: 15.08 (+0.44), ADUS: 27.60 (-0.33), PENX: 18.98 (+0.14), EBIX: 29.77 (+0.86), CORT: 6.44 (+0.38), SWHC: 14.68 (-0.12), OCFC: 16.93 (+0.01)
Nasdaq stocks posting largest percentage increases
AP - Fri Mar 20, 12:25PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
BIIB: 423.57 (+1.46), GLMD: 10.00 (-0.12), HIIQ: 7.36 (-0.24), VTAE: 14.04 (+0.02), CLDN: 13.59 (-2.77), ATRA: 63.79 (+7.64), VBLT: 4.37 (-0.08), CORT: 6.44 (+0.38), FPRX: 24.07 (-0.85)
Corcept Therapeutics (CORT) Is Weak On High Volume Today
at The Street - Fri Mar 20, 9:02AM CDT
Trade-Ideas LLC identified Corcept Therapeutics (CORT) as a weak on high relative volume candidate
CORT: 6.44 (+0.38)
111.8% Return Seen to Date on SmarTrend Corcept Therapeutics Call (CORT)
Comtex SmarTrend(R) - Wed Mar 18, 4:51PM CDT
SmarTrend identified an Uptrend for Corcept Therapeutics (NASDAQ:CORT) on June 12th, 2014 at $2.47. In approximately 9 months, Corcept Therapeutics has returned 111.76% as of today's recent price of $5.22.
CORT: 6.44 (+0.38)
Cortendo announces new board members at Extraordinary General Meeting
M2 - Wed Mar 18, 3:20AM CDT
Cortendo AB (NOTC-A:CORT), a biopharmaceutical company focused on orphan endocrine disorders, announced on Tuesday that at the Extraordinary General Meeting held in Goteborg, John H. Johnson was elected, for the period until the end of the next annual general meeting, as new chairman of the board of directors.
CORT: 6.44 (+0.38)
Corcept Therapeutics (CORT) Jumps: Stock Rises 14.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 12, 8:04AM CDT
Corcept Therapeutics Incorporated (CORT) was a big mover last session, as the company saw its shares rise over 14% on the day.
LCI: 66.45 (-0.28), CORT: 6.44 (+0.38)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Mar 11, 11:47AM CDT
BAK: 8.04 (+0.21), MELA: 1.52 (-0.14), ZGNX: 1.63 (-0.02), EOX: 0.61 (-0.02), MRD: 19.19 (+0.06), ULTR: 1.36 (+0.01), BLT: 13.63 (+0.28), RESN: 3.77 (-0.06), GBSN: 4.98 (+1.44), CYTX: 0.96 (-0.09), WRES: 1.15 (-0.02), MTL: 1.29 (-0.01), VRA: 14.16 (-0.69), CTP: 3.89 (+0.08), ENRJ: 1.75 (+0.05), CORT: 6.44 (+0.38), CBMG: 32.14 (+2.21), SPP: 2.14 (+0.07), CAPN: 6.99 (-0.29), SZYM: 3.71 (-0.06)
Piper upgrades Corcept and sets a $9 price target
Seeking Alpha - at Seeking Alpha - Wed Mar 11, 10:54AM CDT
CORT: 6.44 (+0.38)
Upgrade Alert for Corcept Therapeutics (CORT)
Comtex SmarTrend(R) - Wed Mar 11, 7:07AM CDT
Corcept Therapeutics (NASDAQ:CORT) was upgraded from Neutral to Overweight at Piper Jaffray today. The stock closed yesterday at $3.37 on volume of 144,000 shares, above average daily volume of 117,000. Corcept Therapeutics (NASDAQ:CORT) is currently priced 18.4% above its average consensus analyst price target of $2.75. Corcept Therapeutics shares have support at the 50-day moving average (MA) of $3.13 and additional support at the 200-day MA of $2.86.
CORT: 6.44 (+0.38)
How Alan Leong Of BioWatch News Keeps Successful Biotech Investing Simple
Life Sciences Report - Seeking Alpha - Thu Mar 05, 4:53PM CST
Biotechnology can be daunting to comprehend, but understanding is critical to successful investment. BioWatch News Founder Alan Leong has a nose for growth names, and his goal is to make their technology platforms clear to investors who might not...
CTRV: 3.13 (-0.07), GLMD: 10.00 (-0.12), PTBI: 3.37 (+0.20), CNAT: 6.31 (-0.15), GALT: 3.29 (+0.01), SRNE: 10.36 (-0.43), CELG: 115.54 (+0.72), GILD: 104.18 (-1.02), KITE: 57.56 (-1.43), CFRX: 5.39 (-0.05), ICPT: 280.45 (-8.26), JUNO: 55.72 (-0.68), CORT: 6.44 (+0.38)
Corcept reports 4Q loss
Automated Insights - Wed Mar 04, 3:54PM CST
MENLO PARK, Calif. (AP) _ Corcept Therapeutics Inc. (CORT) on Wednesday reported a loss of $3.9 million in its fourth quarter.
CORT: 6.44 (+0.38)
Corcept Therapeutics beats by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 3:15PM CST
CORT: 6.44 (+0.38)
The Top Small Cap Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Sun Feb 22, 2:51AM CST
MATW: 50.74 (+0.08), RTIX: 5.69 (-0.10), ELLI: 57.00 (-0.45), KFRC: 22.02 (-0.13), SILC: 41.72 (+0.45), SGMO: 14.37 (-0.03), AFFX: 12.57 (-0.13), BABY: 41.64 (+1.71), HBIO: 6.06 (-0.29), EXAM: 42.52 (-0.16), IART: 59.75 (-0.26), UEIC: 57.71 (+0.45), CNMD: 49.35 (+0.36), BJRI: 50.54 (-1.00), NLNK: 53.12 (-0.07), CTRN: 24.27 (+0.16), ANAC: 66.45 (-0.22), CSU: 26.62 (+0.09), RRGB: 80.99 (-2.02), DIOD: 28.02 (+0.12), DEPO: 27.14 (+0.65), DYAX: 28.12 (+0.15), FARO: 44.64 (-0.93), PERY: 24.97 (-0.22), PACB: 5.90 (-0.07), PFPT: 58.45 (-0.45), MTSI: 34.46 (-0.27), IRWD: 15.07 (-0.19), ABAX: 63.25 (-0.09), SCSS: 34.12 (+0.30), ANIP: 69.79 (+1.24), FORM: 9.44 (+0.05), BEAT: 8.82 (-0.13), QLGC: 15.08 (+0.44), PENX: 18.98 (+0.14), EBIX: 29.77 (+0.86), CORT: 6.44 (+0.38), UTMD: 56.00 (+0.90), DAVE: 29.37 (+0.05), SWHC: 14.68 (-0.12)
Cortendo's resolutions on new share issues at Extraordinary General Meeting approved
M2 - Wed Feb 04, 5:28AM CST
Cortendo AB (NOTC-A:CORT)(OTC:CRTOF), a biopharmaceutical company focused on orphan endocrine disorders, on Tuesday reported the holding of an Extraordinary General Meeting in Goteborg.
CORT: 6.44 (+0.38)
Earnings Update: Corcept Therapeutics
Clinically Sound Investor - at Seeking Alpha - Fri Jan 30, 1:13PM CST
CORT: 6.44 (+0.38)
